Evidence map›Paper›PMID 31004524›Full record

ArticleHepatology (Baltimore, Md.)2019

Impaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid-Dependent and Transmissible Microbial Adaptations.

Yan Xie, Hitoshi Matsumoto, Susan Kennedy, Elizabeth P Newberry, William Moritz, Brian J DeBosch, Kelle H Moley, Deborah C Rubin, Brad W Warner, Andrew L Kau and 4 more

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Environmentally AcquiredBiomedicines · 2022
    Article
  6. Fecal microbiome and bile acid metabolome in adult short bowel syndrome.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yan XieDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Hitoshi MatsumotoDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Susan KennedyDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Elizabeth P NewberryDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
William MoritzDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Brian J DeBoschDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Kelle H MoleyDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO.
Deborah C RubinDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Brad W WarnerDepartment of Surgery, Washington University School of Medicine, St. Louis, MO.
Andrew L KauDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Phillip I TarrDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Todd N WylieDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Kristine M WylieDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Nicholas O DavidsonDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Washington University in St. Louis · USJames S. McDonnell Foundation · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
HEPATIC SYNTHESIS AND SECRETION OF APOLIPOPROTEIN (A)R01DK056260 · NIDDK · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 1999 to 2017
$5.9M
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS.R37HL038180 · NHLBI · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 2000 to 2009
$5.1M
MOLECULAR AND METABOLIC ASPECTS OF IMPLANTATIONR01HD065435 · NICHD · WASHINGTON UNIVERSITY · PI KOMMAGANI, RAMAKRISHNA, SANTI, CELIA M · 2010 to 2020
$4.5M
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESISR01HL038180 · NHLBI · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O. · 1986 to 2018
$3.8M
Impaired VLDL secretion, progression and reversal of hepatic fibrogenesisR01DK119437 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2019 to 2026
$3.8M
SLO3 KO MOUSE: A TOOL TO REVEAL VOLTAGE-DEPENDENT PROCESSES IN SPERM FERTILITYR01HD069631 · NICHD · WASHINGTON UNIVERSITY · PI SANTI, CELIA M · 2011 to 2022
$3.3M
Maternal nutrition and oocyte programmingR01HD083895 · NICHD · WASHINGTON UNIVERSITY · PI ENGLAND, SARAH K. · 2015 to 2019
$2.7M
MYOFIBROBLAST REGULATION OF THE STEM CELL NICHE IN SHORT BOWEL SYNDROMER01DK106382 · NIDDK · WASHINGTON UNIVERSITY · PI RUBIN, DEBORAH C. · 2015 to 2018
$1.4M
Bile acid metabolomics and metagenomics in short bowel syndromeR01DK112378 · NIDDK · WASHINGTON UNIVERSITY · PI DAVIDSON, NICHOLAS O., RUBIN, DEBORAH C. · 2016 to 2018
$1.1M
Manpei Suzuki Diabetes FoundationNHLBI NIH HHS R01 HL038180NHLBI NIH HHS R37 HL038180NIAID NIH HHS K08 AI113184NICHD NIH HHS R01 HD065435NICHD NIH HHS R01 HD069631NICHD NIH HHS R01 HD083895NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK056260NIDDK NIH HHS R01 DK106382NIDDK NIH HHS R01 DK112378NIDDK NIH HHS R01 DK119437Robert Wood Johnson Foundation
6 · The paper itself

Abstract

The mechanisms by which alterations in intestinal bile acid (BA) metabolism improve systemic glucose tolerance and hepatic metabolic homeostasis are incompletely understood. We examined metabolic adaptations in mice with conditional intestinal deletion of the abetalipoproteinemia (ABL) gene microsomal triglyceride transfer protein (Mttp-IKO), which blocks chylomicron assembly and impairs intestinal lipid transport. Mttp-IKO mice exhibit improved hepatic glucose metabolism and augmented insulin signaling, without weight loss. These adaptations included decreased BA excretion, increased pool size, altered BA composition, and increased fibroblast growth factor 15 production. Mttp-IKO mice absorb fructose normally but are protected against dietary fructose-induced hepatic steatosis, without weight loss or changes in energy expenditure. In addition, Mttp-IKO mice exhibit altered cecal microbial communities, both at baseline and following fructose feeding, including increased abundance of Bacteroides and Lactobacillus genera. Transplantation of cecal microbiota from chow-fed Mttp-IKO mice into antibiotic-treated wild-type recipients conferred transmissible protection against fructose-induced hepatic steatosis in association with a bloom in Akkermansia and increased Clostridium XIVa genera, whose abundance was positively correlated with fecal coprostanol and total neutral sterol excretion in recipient mice. However, antibiotic-treated Mttp-IKO mice were still protected against fructose-induced hepatic steatosis, suggesting that changes in microbiota are not required for this phenotype. Nevertheless, we found increased abundance of fecal Akkermansia from two adult ABL subjects with MTTP mutations compared to their heterozygous parents and within the range noted in six healthy control subjects. Furthermore, Akkermansia abundance across all subjects was positively correlated with fecal coprostanol excretion. Conclusion: The findings collectively suggest multiple adaptive pathways of metabolic regulation following blocked chylomicron assembly, including shifts in BA signaling and altered microbial composition that confer a transmissible phenotype.

Indexed as

Adaptation, PhysiologicalAkkermansiaAnimalsBile Acids and SaltsBiological TransportCarrier ProteinsChylomicronsDisease Models, AnimalFatty LiverFructoseGastrointestinal MicrobiomeGlucose Tolerance TestHumansIntestinal MucosaLipid MetabolismMiceBile Acids and SaltsCarrier ProteinsChylomicronsFructose

Identifiers

PMID31004524
PMCPMC6783349
OpenAlexW2939423193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.